S&CO Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
S&CO Inc's NBIX Position: Q3 2026 in Review
S&CO Inc held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 7,000 shares worth $992K. The position accounts for 0.06% of the portfolio, ranked #144.
S&CO Inc first reported a position in NBIX in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.18M in Q2 2026. 766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- S&CO Inc held 7,000 shares of Neurocrine Biosciences worth $992K as of Q3 2026.
- S&CO Inc left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up 0.06% of S&CO Inc's portfolio in Q3 2026, its #144 holding.
- S&CO Inc first reported a position in Neurocrine Biosciences in Q1 2024 and has held it in 11 quarters since.
- S&CO Inc's Neurocrine Biosciences position peaked at $1.18M in Q2 2026.
- 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on S&CO Inc's 13F filing for Q3 2026, filed 10 Nov 2026.